Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

4.280 -0.360 (-7.76%)
Delayed Quote Updated: 10:51 AM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 231,038
Open 4.350
Bid (Size) 4.220 (200)
Ask (Size) 4.340 (100)
Prev. Close 4.640
Today's Range 4.200 - 4.410
52wk Range 2.350 - 1,260.00
Shares Outstanding 171,350,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluation of strategic alternatives Jaguar's rare disease intestinal failure development program for... 
From Jaguar Health, Inc.
Via ACCESS Newswire
News headline image
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and short bowel syndrome (SBS) for crofelemer powder... 
From Jaguar Health, Inc.
Via ACCESS Newswire

Performance

52-Week Range 99.7% below 52-week high
4.280
2.3552W Low 1,260.0052W High
1 Week 41.1% below 1-week high
4.321W Low 7.271W High

Jaguar Health, Inc. - Common Stock (JAGX) traded between $2.35 and $1,260.00 over the past 52 weeks and last traded at $4.28, 99.7% below its 52-week high. Over the past week it ranged between $4.32 and $7.27.

Past 12 Months
-23.8%
-10.5%
-87.3%
-97.9%
-99.2%
-99.6%
1W -$1.34
1M -$0.50
3M -$29.47
6M -$200.47
YTD -$519.41
1Y -$1,113.97

JAGX was -99.6% over the past year, -97.9% over six months, -99.2% year to date, -23.8% in the last week.

12 Months vs Market
JAGX
-99.6%
DIA
+12.4%
SPY
+17.3%
QQQ
+23.3%
IWM
+13.1%

Over the past 12 months JAGX returned -99.6% versus DIA (Dow) +12.4%, SPY (S&P 500) +17.3%, QQQ (Nasdaq 100) +23.3% and IWM (Russell 2000) +13.1%.

Volume & Liquidity 0.12× 3-mo avg
Today 231,038 3-mo avg 2.0M
1W
6.1M
1M
6.1M
3M
2.0M
6M
1.0M
YTD
666.6K
1Y
518.0K

JAGX most recently traded 231,038 shares against a 3-month average daily volume of 2.0M.

More News

Read More
What's going on in today's pre-market session ↗
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session. ↗
Via Chartmill
News headline image
Jaguar Health Announces a Special Stock Dividend
From Jaguar Health, Inc.
Via ACCESS Newswire
News headline image
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting
From Jaguar Health, Inc.
Via ACCESS Newswire
Gapping stocks in Friday's session ↗
Via Chartmill
Unusual volume stocks in Thursday's session ↗
Via Chartmill
The market is filled with gapping stocks in Thursday's session. ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Wednesday's session: top gainers and losers ↗
Via Chartmill
Gapping stocks in Wednesday's session ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
These stocks are moving in today's after hours session ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
News headline image
Jaguar Health Receives Fee Waivers from FDA
From Jaguar Health, Inc.
Via ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Keep an eye on the top gainers and losers in Tuesday's session. ↗
Via Chartmill
News headline image
Jaguar Health, Inc. Announces Reverse Stock Split
From Jaguar Health, Inc.
Via ACCESS Newswire
News headline image
All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
From Jaguar Health, Inc.
Via ACCESS Newswire
Top movers analysis one hour before the close of the markets on 2026-09-08: top gainers and losers in today's session. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-09-08: top gainers and losers in today's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
From Jaguar Health, Inc.
Via ACCESS Newswire
Curious about the stocks that are showing activity after the closing bell on Monday? ↗
Via Chartmill

Frequently Asked Questions

Is Jaguar Health, Inc. - Common Stock publicly traded?
Yes, Jaguar Health, Inc. - Common Stock is publicly traded.
What exchange does Jaguar Health, Inc. - Common Stock trade on?
Jaguar Health, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Jaguar Health, Inc. - Common Stock?
The ticker symbol for Jaguar Health, Inc. - Common Stock is JAGX on the Nasdaq Stock Market
What is the current price of Jaguar Health, Inc. - Common Stock?
The current price of Jaguar Health, Inc. - Common Stock is 4.280
When was Jaguar Health, Inc. - Common Stock last traded?
The last trade of Jaguar Health, Inc. - Common Stock was at 10/13/26 10:51 AM ET
What is the market capitalization of Jaguar Health, Inc. - Common Stock?
The market capitalization of Jaguar Health, Inc. - Common Stock is 733.38M
How many shares of Jaguar Health, Inc. - Common Stock are outstanding?
Jaguar Health, Inc. - Common Stock has 733M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.